Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Genix Pharmaceuticals Corp GENPF


Primary Symbol: V.GENX

Consumer Defensive Industrials Household & Personal Products Business Services
Genix Pharmaceuticals Corporation is a nutraceutical and generic ophthalmic drugs company. The Company is focused on the research, development, manufacturing, licensing, and sales of healthcare products. Its products include evidence-based, proprietary over the counter (OTC) nutraceuticals, and other single-molecule generic drugs. The Company is engaged in marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Bimatoprost 0.01% Eye Drops, Timolol 0.5% Eye Drops, Loteprednol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Brimonidine 0.2% Eye Drops. The Company sells its ophthalmic products through traditional pharmacy and drugstore retail outlets and as well as direct to consumers and e-commerce platforms.


TSXV:GENX - Post by User

Genix Pharmaceuticals Corp > Coule be a game changer Whitehorse hc approval!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(188)
•••
Post by Sonbosson Jul 14, 2020 2:25pm
297 Views
Post# 31266680

Coule be a game changer Whitehorse hc approval!

Coule be a game changer Whitehorse hc approval!
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-enters-definitive-130000064.html

"We are truly excited about acquiring the global rights to Flu-X®. It was used safely and effectively in China during the SARS-CoV epidemic and has been shown to be effective against several coronaviruses1," stated Sina Pirooz, the Company's CEO. "Since there are striking similarities between the SARS and COVID-19 coronaviruses, we are encouraged about the potential of Flu-X® on COVID-19," added Mr. Pirooz

GENIX plans to commence global sales of Flu-X® immediately and in Canada once regulatory approval


Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
https://finance.yahoo.com/news/genix-pharmaceuticals-corporation-completes-purchase-090000198.html


Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
https://finance.yahoo.com/news/genix-acquires-exclusive-rights-sucanon-194200744.html
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities